Mechanical activation of Piezo1 promotes osteoclastogenesis in orthodontic tooth movement Authors: Fu Zheng, Tong Wu, Feifei Wang, Xinyu Cui, Hongyi Tang, Peng Chen, Cuiying Li, Jiuhui Jiang Published: 2026 ABSTRACT AbstractBackgroundThe initiation of bone remodeling by periodontal ligament cells (PDLCs) in response to force is pivotal for mediating orthodontic tooth movement (OTM). Piezo1 plays a pivotal role in the process of bone remodeling under mechanical stimulation. Our objective was to elucidate the role and mechanism of Piezo1 in force-treated PDLCs, and its influence on orthodontic bone remodeling.MethodsHuman PDLCs (hPDLCs) were isolated and treated with compressive force, along with either si-PIEZO1 or Yoda1. The expression of Piezo1 and the receptor activator of NF-kB ligand/osteoprotegerin (RANKL/OPG) ratio were assessed by quantitative real-time polymerase chain reaction (qPCR) and Western blots. Intracellular calcium ion influx was assessed with Fluo4-AM staining. The effect of force-treated hPDLCs on the osteoclastic differentiation of RAW264.7 cells was analyzed by tartrate-resistant acid phosphatase (TRAP) staining, qPCR and Western blots. After constructing the OTM model, rats were injected with GsMTx4 or Yoda1. OTM distance, osteoclast differentiation, and the expression of RANKL and phosphorylated-ERK1/2 was analyzed with micro-computed tomography, hematoxylin and eosin, TRAP, immunofluorescence and immunohistochemistry staining.ResultsCompressive force-activated Piezo1 in hPDLCs mediated RANKL/OPG upregulation via ERK1/2 phosphorylation, thereby facilitating osteoclast differentiation. Yoda1 amplified this effect, while knocking down Piezo1 suppresses it in force-treated hPDLCs. In vivo, Yoda1 enhanced OTM and osteoclastogenesis in rats, while GsMTx4 inhibited these processes. The expression of phosphorylated-ERK1/2 in periodontal ligaments on the compressive side was enhanced by Yoda1 and attenuated by GsMTx4.ConclusionsCompressive force-activated Piezo1 in PDLCs triggers the osteoclast differentiation and orthodontic bone remodeling via ERK1/2 signal pathway.Graphical AbstractCompressive force activates Piezo1 in PDLCs, triggering calcium influx, ERK phosphorylation, and elevated RANKL expression. This enhances osteoclast differentiation, promoting bone remodeling and facilitating orthodontic tooth movement. Supplementary InformationThe online version contains supplementary material available at 10.1186/s12903-026-08800-x.Keywords: Compressive force, Extracellular signal-regulated kinases, Orthodontic tooth movement, Osteoclastogenesis, Periodontal ligament cells, Piezo1 Background Malocclusion has adverse effects on the oral, physical and mental health of patients [1–3]. Orthodontic treatment is effective in correcting malocclusion, which is beneficial for enhancing patients' confidence and overall health. Orthodontic tooth movement (OTM) depends on mechanically mediated bone remodeling [4]. The application of mechanical force stimulates various cells to generate biological signals, thereby initiating local bone remodeling [5–7]. After force application, the tension side is characterized mainly by bone deposition, while the pressure side is characterized mainly by bone resorption [4]. The rate of bone resorption on the pressure side is considered as the limiting step for OTM, and is closely linked to the osteoclast differentiation and activity on the pressure side [8–10]. Periodontal ligament cells (PDLCs) can sense force stimulation and release cytokines and inflammatory factors, thereby recruiting immune cells such as macrophages [11–14]. The differentiation of osteoclasts during OTM relies significantly on the expression of receptor activator of NF-kB ligand (RANKL) by PDLCs in response to mechanical stimulation [7, 11, 14, 15]. The mechanism by which PDLCs transduce mechanical signals into biological cues, fostering the expression of RANKL, remains unclear. Therefore, further investigation is warranted. Piezo1 is a transmembrane ion channel protein which senses mechanical signals and triggers calcium ion influx, leading to subsequent biological reactions [16, 17]. Piezo1 plays a significant role in the development and homeostasis of bone [18–20]. Piezo1 can modulate mechanical force-induced periodontium remodeling. Occlusal force activates Piezo1 of PDLCs, thus contributing to the maintenance of periodontal homeostasis [21, 22]. Orthodontic tension can activate Piezo1 in PDLCs, causing bone remodeling on the tension side [23, 24]. It has also been found that mechanical pressure can activate Piezo1 in PDLCs, thereby influencing the osteogenic and osteoclastic activities through the β-catenin signaling pathway [25]. Additionally, compressive loading upregulates the ratio of RANKL to osteoprotegerin (RANKL/OPG) in periodontal ligament fibroblasts (PDLFs) through Piezo1 [26, 27]. Yoda1 is known to activate the Piezo1 ion channel, influencing cellular biological behaviors [28]; however, no studies have yet explored whether exogenous injection of Yoda1 to pre-activate Piezo1 affects OTM and bone remodeling. And the signaling pathway through which mechanical force activates RANKL expression in PDLCs via Piezo1 remains unclear and needs further investigation. Extracellular signal-regulated kinases 1/2 (ERK1/2) plays a crucial role in bone remodeling processes [29, 30]. During orthodontic treatment, compression of PDLCs leads to increased phosphorylation of ERK1/2, thereby upregulating RANKL expression and promoting the differentiation of osteoclasts downstream [11, 15]. And the activation of ERK1/2 links to calcium influx. Ultrasound stimulation can activate Piezo1 in MC3T3-E1 cells, inducing calcium influx, activating ERK1/2, and promoting cell proliferation [31]. Hydrostatic pressure promotes osteogenic differentiation of bone marrow stem cells (BMSCs) through the Piezo1-mediated activation of ERK1/2 [32]. Piezo1 activation inhibited the growth of hepatoma cells via ERK1/2 signaling pathway [33]. Nevertheless, the precise role of ERK1/2 in the mechanism by which force-activated Piezo1 promotes RANKL expression in PDLCs remains unclear. In this study, we established an OTM model in rats and isolated human periodontal ligament cells (hPDLCs) exerting mechanical loading in vitro. Piezo1 functional activation and inhibition assays were used to explore the role and mechanism of Piezo1 in PDLCs induced osteoclast differentiation during OTM. Methods Ethic statement All research protocols were approved by the Ethics Committee of Peking University School of Stomatology, Beijing, China (PKUSSIRB-202385020). We obtained informed consent from all donors and their legal guardians prior to collecting samples. All animal experiments conducted in this study followed standard procedures and adhered to ethical principles for animal welfare. The animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Peking University (LA2022288). Isolation and culture of hPDLCs HPDLCs were isolated from premolars extracted for orthodontic reasons from three patients (aged 18–25) using an established protocol [7, 34]. Cells from the three individuals were initially cultured separately up to passage 1 (P1). At passage 2 (P2), equal numbers of cells from each donor were pooled and cultured together in α-MEM (12,571,063, Gibco, Grand Island, NY, USA) supplemented with 15% fetal bovine serum (FBS; A5670701, Gibco), 0.292 mg/mL glutamine (A2916801, Gibco), 100 U/mL penicillin and 100 μg/mL streptomycin (P1400, Solarbio, Beijing, China) and incubated at 37 °C in a humidified atmosphere containing 5% CO2. Experiments were conducted with cells at passages 3–6. Force application to hPDLCs To apply compressive force, hPDLCs at 70%–80% confluence were exposed to static mechanical pressure using a sterile glass coverslip loaded with a calibrated metal ball, as previously described [11, 35]. The compressive force was standardized and calculated based on the weight and area of the metal ball, yielding pressures of 0.5, 1.0, or 2.0 g/cm2. Cells were subjected to pressure for 12 h to assess dose response, or at 1.0 g/cm2 for 0, 6, 12, or 24 h to assess time dependency. After compression, cells were harvested for quantitative real-time polymerase chain reaction (qPCR) and Western blot analysis. Small interfering RNA (siRNA) transfection and Yoda1 stimulation of hPDLCs Si–H-PIEZO1 (siG150327130626-1–5, RiboBio, Guangzhou, China) was used to knockdown the Piezo1 of hPDLCs. SiR NC #2 (siN0000002-1–5, RiboBio) was used as a control. Following the manufacturer’s instructions for the RiboFECT™ CP Transfection Kit (C10511-05, RiboBio), the transfection reagent mixture was added to the medium once the cells reached 70–80% confluence for 48 h. Afterward, the transfection medium was replaced with the regular culture medium. Yoda1 (S6678, Selleck, Houston, TX, USA) was dissolved in dimethyl sulfoxide (DMSO; D8371 Solarbio) to prepare a stock solution of 50 mM. HPDLCs were treated with Yoda1 at a final concentration of 10 μM for 12 h synchronously with mechanical stimulation[36]. For the control group, an equivalent volume of DMSO was supplemented. Conditioned medium and the osteoclastic induction of RAW264.7 cells The RAW264.7 cell line was obtained from the American Type Culture Collection (ATCC) and used to explore the role of hPDLCs in regulating osteoclast differentiation following the previous studies[11, 15]. Only mycoplasma-negative cells were used for subsequent experiments (Mycoplasma PCR Detection Kit, C0301S; Beyotime, Shanghai, China). The cells were cultured in high-glucose DMEM (11,965,092, Gibco) supplemented with 10% FBS (Gibco) and incubated at 37 °C in a humidified atmosphere containing 5% CO2. The culture medium of the hPDLCs in each group was collected after removing mechanical stimulation. After centrifugation at 2000 g for 10 min, the supernatant was retained and stored at −20 °C. Conditioned medium consisting of 50% supernatant, 50% DMEM and 10 ng/ml RANKL (R&D, Emeryville, MN, USA) [37] was used to induce osteoclastic differentiation (Fig. 2E, cited here to aid understanding of the experimental procedure despite being presented later in the figure sequence). The conditioned medium was changed every 3 days. Cells were collected for qPCR, Western blot analysis and tartrate-resistant acid phosphatase (TRAP) staining after osteoclastic induction for 5 days. TRAP staining was performed using an acid phosphatase kit (387A-1KT; Sigma, St. Louis, MO, USA) according to the manufacturer's instructions. TRAP-positive, multinucleated (≥ 3 nuclei) cells were counted in each well. Each experiment was repeated three times. The expression of receptor activator of nuclear factor kappa-Β ligand/Osteoprotegerin (RANKL/OPG) and the promotion of osteoclast differentiation in force-treated human periodontal ligament cells (hPDLCs) were inhibited by si-PIEZO1. A. Representative fluorescence images of Fluo4 and semiquantitative analysis of intracellular calcium levels in hPDLCs treated with si-PIEZO1 and force. (n = 3) Scale bar: 25 μm. B. Representative flow cytometry plots of Fluo4 in hPDLCs and Semiquantitative analysis of FITC-positive (Fluo-4-labeled) cells, (n = 3). C-D. Real-time polymerase chain reaction (qPCR) and Western blots analysis results of Piezo1, RANKL and OPG in hPDLCs treated with si-PIEZO1 and force, (n = 3). E. Diagram of the experimental protocol. Supernatant of treated PDLCs were used to stimulate RAW264.7 cells osteoclastic differentiation. F. Representative tartrate-resistant acid phosphatase (TRAP) staining images of RAW264.7 cells treated with conditioned medium and semiquantitative analysis of TRAP-positive osteoclasts, (n = 3). Scale bar: 200 μm. G. qPCR results of Acp5, Ctsk, Mmp9 and Nfatc1 in RAW264.7 cells treated with conditioned medium, (n = 3). H-I. Western blots analysis results of MMP9 and NFATC1 in RAW264.7 cells treated with conditioned medium. Data represent mean ± SEM. p values were calculated using one-way ANOVA with Tukey’s multiple comparisons test and are indicated directly in the figure. All experiments were independently repeated three times. CM, Conditioned medium. TRAP, tartrate-resistant acid phosphatase Intracellular calcium detection in hPDLCs After transfection with siRNA, the culture medium was removed, and the cells were washed 3 times with sterile PBS buffer. Culture medium supplemented with 5 μM Fluo4-AM (S1060; Beyotime, Beijing, China) was added to the cell plates, followed by incubation of the cells under mechanical force. For the Force + Yoda1 group, culture medium supplemented with 5 μM Fluo4-AM and 10 μM Yoda1 were added to the cell plates synchronously with mechanical stimulation. For the Force + DMSO group, an equal volume of DMSO was added to the culture medium. Afterward, the cells were incubated in a 37 °C incubator in the dark for 30 min. Then the force device was removed, the reagent was washed off, and the cells were fixed at room temperature with 4% paraformaldehyde (PFA; P1110, Solarbio) for 15 min. For fluorescence detection, cells were sealed with mounting medium containing 4',6-diamidino-2-phenylindole (DAPI; S2110, Solarbio) after PBS washing. And cell images of the cells were captured using an inverted confocal microscope (FV3000, Olympus, Tokyo, Japan). ImageJ software (Media Cybernetics, Bethesda, MD, United States) was employed for the analysis of the fluorescence intensity of the staining. For flow cytometry (NovoCyte, Agilent, Santa Clara, CA, USA), cells were also collected, resuspended, and analyzed. FITC-positive cells were then counted [38]. qPCR We extracted RNA from hPDLCs and RAW264.7 cells using TRIzol reagent (15596018CN, Invitrogen, Carlsbad, CA, USA) as per the manufacturer’s guidelines. qPCR analyses were performed following standard protocols as previously described [35, 39]. The 2−ΔΔCq method was used for comparative quantitation. The expression levels of the target genes were determined relative to those of glyceraldehyde 3-phosphate dehydrogenase (GAPDH/Gapdh) using the primers listed in Table S1 and Table S2, which were designed using Primer Premier 5.0 software. All PCR assays were performed in triplicate. Western blot analysis Radioimmunoprecipitation assay lysis buffer (R0010, Solarbio), supplemented with protease (P0100, Solarbio) and phosphatase inhibitor (P1260, Solarbio) mixture was used to extract total protein from cultured cells. Western blot analyses were performed following standard protocols as previously described [35, 39]. The primary antibodies used in this research were shown in Table S3. The analysis of immunoreactive bands employed GAPDH as the reference by ImageJ software (Media Cybernetics, Bethesda, MD, United States). Rat OTM model Sprague Dawley (SD) rats (male, 6-week-old, 200 ± 20 g) were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). Anesthesia was induced using pentobarbital sodium (40 mg/kg), and orthodontic force was applied using a closed-coil spring (Tomy, Japan) following an established method [35, 40, 41]. The spring, ligated to the maxillary first molar and incisor using stainless-steel wire, exerted a 50 g force to move the first molar mesially, with force consistency ensured by a gauge (3 M Unitek, USA) [11, 24, 41]. To secure the device, a groove was created on the incisor, which was filled with resin (3 M Unitek). After recovery, rats were fed soft food daily. Grouping for experimental treatments The overall animal experiment required 30 rats, divided into two parts. In the first part, a total of 15 rats are randomly assigned to three groups (Control + DMSO, Force + DMSO and Force + Yoda1 group), each comprising 5 rats. The second part involved a total of 15 rats, randomly assigned to three groups (Control + PBS, Force + PBS and Force + GsMTx4 group), with 5 rats in each group. To investigate the role of Piezo1 in the OTM, rats were treated with GsMTx4 (P1205, Selleck). The rats in Force + GsMTx4 group received a subcutaneous injection of the Piezo1 inhibitor GsMTx4 at a dosage of 100 μl/kg and a concentration of 10 μM every other day [24, 34], and the other groups received only the vehicle (PBS) (Fig. 3A, cited here to aid understanding of the experimental procedure despite being presented later in the figure sequence). Yoda1 (S6678, Selleck) was employed to investigate the effects of exogenous Yoda1 activation of Piezo1 on OTM tissue remodeling. The rats in the Force + Yoda1 group received an intraperitoneal injection of the Piezo1 agonist Yoda1 at a dosage of 100 μl/kg and a concentration of 25 μM every other day according to the instructions of the manufacturer and previous studies [21, 34, 42]; the other groups received only the vehicle (DMSO + PBS) (Fig. 5A, cited here to aid understanding of the experimental procedure despite being presented later in the figure sequence). GsMTx4 inhibited orthodontic tooth movement (OTM) and osteoclastic differentiation in rats. A. Schematic diagram of the experimental design, showing force application and local GsMTx4 injection. B. Representative micro-CT images and semiquantitative analysis of OTM distance after orthodontic force and GsMTx4 application. The white arrow indicated the force direction (n = 5). C. Representative images of hematoxylin and eosin staining and tartrate-resistant acid phosphatase (TRAP) staining. Semiquantitative analysis of the number of TRAP-positive osteoclasts attached to alveolar bone. The long black arrow indicated the force direction. The short black arrows indicated TRAP-positive multinucleated osteoclasts (n = 5). Scale bar: 50 μm. D. Representative images of RANKL immunofluorescence staining and semiquantitative analysis of RANKL-positive cells in the periodontal ligament on the compressive side. The long white arrow indicated the force direction (n = 5). Scale bar: 50 μm. Data represent mean ± SEM. p values were calculated using Student’s t-test or one-way ANOVA with Tukey’s multiple comparisons test, as appropriate. Exact p values are indicated directly in the figure. OTM, Orthodontic tooth movement; R, The distal buccal root of maxillary first molar; PDL, Periodontal ligament; AB, Alveolar bone Yoda1 promoted orthodontic tooth movement (OTM) and osteoclastogenesis in rats. A. Schematic diagram of the experimental protocol showing orthodontic force application and intraperitoneal injection of Yoda1. B. Representative micro-CT images and semiquantitative analysis of OTM distance after orthodontic force and Yoda1 application. The white arrow indicated the force direction (n = 5). C. Representative images of hematoxylin and eosin staining and tartrate-resistant acid phosphatase (TRAP) staining. Semiquantitative analysis of the number of TRAP-positive osteoclasts attached to alveolar bone. The long black arrow indicated the force direction. The short black arrows indicated TRAP-positive multinucleated osteoclasts (n = 5). Scale bar: 50 μm. D. Representative images of RANKL immunofluorescence staining and semiquantitative analysis of RANKL-positive cells in the periodontal ligament on the compressive side. The long white arrow indicated the force direction (n = 5). Scale bar: 50 μm. Data represent mean ± SEM. p values were calculated using Student’s t-test or one-way ANOVA with Tukey’s multiple comparisons test, as appropriate. Exact p values are indicated directly in the figure. OTM, Orthodontic tooth movement; Ip. injection, Intraperitoneal injection; R, The distal buccal root of maxillary first molar; PDL, Periodontal ligament; AB, Alveolar bone Micro-computed tomography (micro-CT) imaging and analysis The rats (n = 5) were sacrificed by an overdose of pentobarbital sodium after 7-days treatment, and then the maxillae were harvested and fixed in 4% PFA (Fig. 3A & 5A). Subsequently, we acquired micro-CT images of the maxillae at a resolution of 8.82 μm, utilizing a tube voltage of 60 kV, a tube current of 500 μA, and an exposure time of 1500 ms. Three-dimensional (3D) reconstructions were performed using multimodal 3D visualization software (Inveon Research Workplace; Siemens, Munich, Germany) [34]. Then, two proficient investigators, both unaware of the group allocation, measured the distance between two easily identifiable points: the midpoint of the distal-marginal ridge of the first molar and the midpoint of the mesial-marginal ridge of the second molar. The mean of these dual measurements was used to calculate the resultant distance of OTM. We conducted an Intraclass Correlation Coefficient (ICC) analysis by SPSS 22.0 (IBM, Armonk, NY, USA) to assess the inter-rater reliability of our measurements (Table S4). Hematoxylin and eosin, Masson's trichrome and tartrate-resistant acid phosphatase staining After fixation, the maxillae were demineralized in 15% ethylenediaminetetraacetic acid (EDTA; G1105, Servicebio, Wuhan, China), dehydrated with graded ethanol and subsequently embedded in paraffin blocks. Thereafter, the samples were cut into 4-μm vertical serial sections with a rotary microtome (RM2125RT, Leica, Heidelberger, Germany), and subjected to staining procedures involving both hematoxylin and eosin (HE) and TRAP according to our established protocol [34, 39]. For TRAP staining, an acid phosphatase kit (387A-1KT; Sigma) was employed, strictly following the guidelines provided by the manufacturer. We performed the quantification of TRAP-positive multinucleated cells (≥ 3 nuclei) attached to the alveolar bone surface. Masson's trichrome staining was performed on adjacent serial sections using a commercial staining kit (G1006, Servicebio, Wuhan, China), following the manufacturer’s instructions. Collagen fibers were stained blue, cytoplasm red, and nuclei dark brown to black. Immunofluorescence and immunohistochemistry of tissue sections For immunofluorescence staining, sections were subjected to antigen retrieval with 0.125% trypsin (Gibco) and 20 μg/mL proteinase K solution (4,333,793, Invitrogen) at 37℃ for 1 h. The slides were blocked with 5% bovine serum albumin (BSA; A8010, Solarbio) for 60 min at room temperature, followed by overnight incubation at 4 °C with primary antibodies as shown in Table S3. Following thorough PBS washing, the sections were incubated with corresponding secondary antibodies (Table S3) at room temperature for 1 h. Subsequently, the tissues were sealed with mounting medium containing 4',6-diamidino-2-phenylindole (DAPI; S2110, Solarbio) after PBS washing. Images were captured using an inverted confocal microscope (FV3000, Olympus). ImageJ software was used for the analysis of positive cells in PDL on the compressive side of each section. For immunohistochemical staining [34, 39], following antigen retrieval, the sections were treated with 3% H2O2 to block endogenous peroxidase activity for 30 min at room temperature. Then, the sections were blocked with 5% BSA for 60 min at room temperature, followed by overnight incubation at 4 °C with primary antibodies as shown in Table S3. After PBS washing, the slides were exposed to HRP-conjugated secondary antibodies and visualized using diaminobenzidine (ZLI-9017; Zsgb-Bio, Beijing, China) as per the manufacturer’s instructions. Subsequently, the sections were counterstained with H&E and examined using a light microscope (BX53, Olympus). The ImageJ software was employed for the analysis of positive cells in PDL on the compressive side of each section. Statistical analysis The analysis of statistical data was executed using Graph Prism 8.0.1. The presentation of data includes mean values accompanied by standard error of the mean (SEM), depending on the analysis, as specified in each figure legend. The Shapiro–Wilk test was employed to verify the normal distribution of the original dataset. Significance was evaluated using both the two-tailed independent Student's t-test and one-way analysis of variance (ANOVA). To further compare ANOVA outcomes, Tukey's multiple-comparison test was adopted. p values less than 0.05 indicated statistical significance. Results Compressive force promoted Piezo1 expression in PDLCs The qPCR results showed that increasing the applied force (0, 0.5, 1, and 2 g/cm2) led to a dose-dependent increase in Piezo1 mRNA expression after 12 h of stimulation (Fig. 1A). The Western blot analysis results demonstrated similar trends in protein levels (Fig. 1B). The time-dependent analysis indicated that under the same force (1 g/cm2), as the force application time increased (0, 6, 12 and 24 h), Piezo1 was progressively upregulated at the mRNA and protein levels (Fig. 1C-D). Therefore, for subsequent experiments, we selected intermediate parameters of force magnitudes and durations (1 g/cm2, 12 h) as stimuli. Immunofluorescence further confirmed that Piezo1 expression is elevated on the compressive side of the PDL, supporting the notion that Piezo1 plays a critical role in mechanotransduction (Fig. 1E-F). These findings suggest that Piezo1 is crucial for the response of PDLCs to mechanical stimuli. Compressive force promoted Piezo1 expression in periodontal ligament cells (PDLCs). A-B. Quantitative PCR (qPCR) and Western blot analyses showing the expression levels of Piezo1 in hPDLCs subjected to increasing magnitudes of compressive force (0, 0.5, 1, or 2 g/cm2) for 12 h (n = 3). A force-dependent upregulation of Piezo1 expression was observed. C-D. Both qPCR and Western blot analyses revealed a time-dependent upregulation of Piezo1 in hPDLCs subjected to 1 g/cm2 compressive force from 0 to 24 h. E. Representative immunofluorescence images showing Piezo1 expression in periodontal ligament tissues under orthodontic compressive force. The white arrow indicated the force direction. Scale bar: 50 μm. F. Semiquantitative analysis of Piezo1-positive cells in the periodontal ligament on the compressive side (n = 5). Data are presented as mean ± SEM, and p values were calculated using Student’s t-test or one-way ANOVA with Tukey’s multiple comparisons test, as appropriate. Exact p values are indicated directly in the figure. All experiments were repeated three times. R: The distobuccal root of maxillary first molar; PDL: Periodontal ligament; AB, Alveolar bone The expression of RANKL/OPG and the promotion of osteoclast differentiation in force-treated hPDLCs were inhibited by si-PIEZO1 RANKL/OPG is a critical signaling pathway in the regulation of osteoclast differentiation. Therefore, this study further investigated whether Piezo1 could influence the expression of RANKL/OPG in force-treated hPDLCs and its subsequent impact on osteoclast differentiation. Knockdown of Piezo1 using si-PIEZO1 resulted in decreased intracellular calcium influx in force-treated hPDLCs (Fig. 2A-B). The qPCR results revealed that upon Piezo1 knockdown, hPDLCs subjected to static pressure exhibited decreased RANKL/OPG ratio in mRNA level (Fig. 2C); The Western blot analysis results indicated similar changes at the protein level (Fig. 2D). The conditioned medium from the Force group effectively promoted the osteoclastic differentiation of RAW264.7 cells, and si-PIEZO1 treatment blocked this effect (Fig. 2F). qPCR revealed that the mRNA levels of Acp5, Mmp9, Ctsk and Nfatc1 in RAW264.7 cells were lower in the conditioned medium of the Force + siPiezo1 group than in that of the Force + siNC group (Fig. 2G). Western blot analysis further revealed significant decreases in the protein expression levels of Mmp9 and Nfatc1 in Raw264.7 cells after treatment with Force + siPiezo1 conditioned medium (Fig. 2H-I). These results indicate that Piezo1 is essential for mediating the effects of mechanical force on the RANKL/OPG and subsequent osteoclast differentiation. GsMTx4 inhibited OTM and osteoclastogenesis in rats GsMTx4, a known Piezo1 inhibitor, was administered to evaluate its effect on OTM and osteoclastogenesis. Following GsMTx4 administration, we observed a decrease in the distance of OTM (Fig. 3B). HE and Masson's trichrome staining indicated that the PDL fiber arrangement was disordered after force application (Fig. 3C & Figure s3). TRAP staining revealed a decrease in the accumulation of TRAP-positive osteoclasts in periodontal tissues after the administration of GsMTx4 during mechanical loading (Fig. 3C). Immunofluorescence staining indicated that GsMTx4 inhibited the expression of RANKL in the periodontium on the compression side (Fig. 3D). All these findings suggest that GsMTx4 effectively inhibits Piezo1-mediated responses to mechanical stress, reducing OTM and osteoclastogenesis. The expression of RANKL/OPG and the promotion of osteoclast differentiation in force-treated hPDLCs were enhanced by Yoda1 Yoda1 is a small molecule activator known for its ability to stimulate the Piezo1 ion channel [21, 28]. After treatment with Yoda1, the intracellular calcium influx was enhanced in force-treated hPDLCs (Fig. 4A-B). The qPCR and Western blot analysis results revealed that Yoda1 enhanced RANKL/OPG ratio in both mRNA and protein level in force-treated hPDLCs (Fig. 4C-D). The expression of receptor activator of nuclear factor kappa-Β ligand/Osteoprotegerin (RANKL/OPG) and the promotion of osteoclast differentiation in force-treated human periodontal ligament cells (hPDLCs) were promoted by Yoda1. A. Representative fluorescence images of Fluo4 and semiquantitative analysis of the intracellular calcium levels in hPDLCs treated with Yoda1 and force, (n = 3). Scale bar: 25 μm. B. Representative flow cytometry plots of Fluo4 in hPDLCs and Semiquantitative analysis of FITC-positive cells, (n = 3). C-D. Real-time polymerase chain reaction (qPCR) and Western blots analysis results of Piezo1, RANKL and OPG in hPDLCs treated with Yoda1 and force, (n = 3). E. Representative tartrate-resistant acid phosphatase (TRAP) staining images of RAW264.7 cells treated with conditioned medium and semiquantitative analysis of TRAP-positive osteoclasts, (n = 3). Scale bar: 200 μm. F. qPCR results of Acp5, Ctsk, Mmp9 and Nfatc1 in RAW264.7 cells treated with conditioned medium, (n = 3). G-H. Western blots analysis results of MMP9 and NFATC1 in RAW264.7 cells treated with conditioned medium. Data represent mean ± SEM. p values were calculated using one-way ANOVA with Tukey’s multiple comparisons test and are indicated directly in the figure. All experiments were independently repeated three times. CM, Conditioned medium. TRAP, tartrate-resistant acid phosphatase Yoda1 treatement enhanced the osteoclast-promoting effect of conditioned medium of force-treated hPDLCs (Fig. 4E). qPCR revealed that the mRNA levels of Acp5, Mmp9, Ctsk and Nfatc1 in RAW264.7 cells were upregulated by the conditioned medium of the Force + Yoda1 group than in the Force + DMSO group (Fig. 4F). Although the mRNA levels in the Force + DMSO group also appeared higher than those in the CM-Control + DMSO group, the difference did not reach statistical significance. This is likely due to the markedly increased expression in the Force + Yoda1 group, which elevated the overall variance among groups and limited the statistical power to detect moderate changes between CM-Control + DMSO and Force + DMSO groups in ANOVA analysis. The Western blot analysis further revealed significant increases in the protein expression levels of Mmp9 and Nfatc1 in RAW264.7 cells after treatment with Force + Yoda1 conditioned medium (Fig. 4G-H). Therefore, we can draw a conclusion that Yoda1 enhances Piezo1-mediated signaling, promoting RANKL/OPG expression and osteoclast differentiation. Yoda1 promoted OTM and osteoclastogenesis in rats Following Yoda1 administration, we observed an increase in the distance of OTM (Fig. 5B). HE and Masson's trichrome staining indicated that the PDL fiber arrangement was disrupted after the application of force (Fig. 5C & Figure s3). There was an increased accumulation of TRAP-positive osteoclasts in periodontal tissues after the administration of Yoda1 during mechanical loading (Fig. 5C). Immunofluorescence staining indicated that Yoda1 promoted the expression of RANKL in the periodontium on the compression side (Fig. 5D). Based on these findings, we proved that Yoda1 effectively promotes OTM and osteoclastogenesis by enhancing Piezo1 activation. Force-induced activation of ERK1/2 was partially dependent on Piezo1 activation in PDLCs To unveil the intermediate molecules through which Piezo1 affects the RANKL/OPG ratio in hPDLCs, we focused on ERK1/2 signal. Following orthodontic force application, there was a notable increase in p-ERK1/2-positive cells within the PDL on the pressure side. However, administration of GsMTx4 reduced the expression of p-ERK1/2, while Yoda1 further enhanced p-ERK1/2 expression (Fig. 6A-B). In vitro, the knockdown of Piezo1 partially blocked the phosphorylation of ERK1/2 in hPDLCs under compressive force (Fig. 6C). On the contrary, Yoda1 stimulation amplified the effect of compressive force. The phosphorylation of ERK1/2 was promoted in the Force + Yoda1 group than in the Force + DMSO group. The lack of significant difference between the Force + DMSO and Control + DMSO groups is likely due to the stronger response seen in the Force + Yoda1 group, which overshadowed the more subtle changes in the Force + DMSO and Control groups (Fig. 6D). Force-induced activation of ERK1/2 was partially dependent on Piezo1 activation in PDLCs. A. Representative images of p-ERK1/2 immunohistochemistry staining and semiquantitative analysis of the number of p-ERK1/2-positive cells in periodontal ligaments (PDL) on the compressive side after orthodontic force and GsMTx4 application. The long black arrow indicated the force direction (n = 5). Scale bar: 50 μm. B. Representative images of p-ERK1/2 immunohistochemistry staining and semiquantitative analysis of the number of p-ERK1/2-positive cells in periodontal PDL on the compressive side after orthodontic force and Yoda1 application. The long black arrow indicated the force direction (n = 5). Scale bar: 50 μm. C. Western blots analysis results of Piezo1, p-ERK1/2 and ERK1/2 in hPDLCs treated with si-PIEZO1 and force. D. Western blots analysis results of p-ERK1/2 and ERK1/2 in hPDLCs treated with force and Yoda1. Data are presented as mean ± SEM. p values were calculated using one-way ANOVA with Tukey’s multiple comparisons test and are indicated directly in the figure. Western blots were repeated three times. R, The distal buccal root of maxillary first molar; PDL, Periodontal ligament; AB, Alveolar bone Discussion This study elucidated the involvement of the Piezo1 ion channel in force-activated PDLCs during OTM. It was found that Piezo1 activation led to enhanced phosphorylation of ERK1/2, resulting in upregulation of RANKL/OPG expression, thereby mediating osteoclast differentiation downstream. These findings align with previous studies that have identified Piezo1 as a critical regulator of mechanotransduction in bone development and remodeling [18, 19, 43, 44]. Several studies have confirmed the mechanosensitive role of Piezo1 in PDLCs under both tension and compression. Occlusal force activated the Piezo1 of leptin receptor+ periodontal ligament stem cells (PDLSCs) and promoted the periodontal tissue growth [21]. Piezo1 activation mediated by occlusal stimulation in PDLCs, leading to intracellular calcium influx, which promoted angiogenesis and osteogenic differentiation through downstream signaling, thereby maintaining alveolar bone homeostasis [22]. The activation of Piezo1 in PDLCs, whether on the tension or compression side, is a crucial factor mediating orthodontically induced periodontal tissue remodeling [23–26]. In the process of bone remodeling, Piezo1 plays dual roles depending on the cellular context and mechanical environment. In mesenchymal stromal cells, its activation promotes osteogenesis via YAP1, Wnt/β-catenin, and RUNX2 signaling [24, 25, 43]. Moreover, Piezo1 has been identified as a mediator of occlusal force in osteoblasts, maintaining alveolar bone homeostasis not only by directly enhancing osteogenic activity but also by sequentially regulating catabolic metabolism through Fas ligand (FasL)-induced osteoclastic apoptosis [45]. However, under different types or durations of mechanical stimulation, Piezo1 activation may trigger NF-κB signaling, thereby inducing inflammatory responses and promoting osteoclastogenesis [27, 46]. Such cell type–specific signaling differences explain why Piezo1 can contribute both to bone formation and bone resorption. In our study, force-induced RANKL/OPG upregulation relied on Piezo1 activation in PDLCs. And RANKL is crucial for osteoclastic differentiation orthodontic bone remodeling [14, 15, 25]. On the compression side, our results support and expand upon studies by Schröder et al., who demonstrated Piezo1 upregulation in PDLCs under static pressure (2 g/cm2), along with enhanced ATP production and inflammatory signaling [26, 27, 47]. Han et al. reported that a static pressure of 2 g/cm2 inhibited the proliferation of human PDLSCs [48]. Therefore, our study established force gradients of 0.5 g/cm2, 1 g/cm2, and 2 g/cm2, and found that even lower force stimulation effectively activated and promoted the expression of Piezo1 in hPDLCs. This suggests that Piezo1 activation may be responsive to a broader range of mechanical forces, though further in vivo studies are necessary to confirm whether this activation exhibits force-dependent characteristics, which may be helpful for exploring the appropriate orthodontic force. The differentiation and function of osteoclasts on the pressure side are key factors influencing the speed of OTM [7, 13, 15]. The present study confirmed that the activation of Piezo1 promoted the osteoclast differentiation mediated by force-treated PDLCs. Conversely, inhibiting or downregulating Piezo1 suppressed the effect of force-treated PDLCs on osteoclast differentiation. This is consistent with previous researchs highlighting the role of Piezo1 in osteoclastogenesis under mechanical stimuli [25–27]. Nevertheless, certain limitations should be acknowledged. Our study employed hPDLC–murine RAW264.7 co-culture rather than fully human cells. While this model is widely accepted and supported by cross-species pathway conservation, species differences may affect certain responses [15]. Future studies using human monocyte–derived osteoclast precursors will therefore be essential to validate and extend our observations in a clinically relevant context. In addition, several studies revealed that the use of Piezo1 agonists such as Yoda1 and JEDI2 can influence osteogenic differentiation and inflammatory response of mesenchymal cells, thereby impacting bone remodeling [26, 49, 50]. Our study demonstrated that intraperitoneal administration of Yoda1, enhanced osteoclast differentiation on the orthodontic pressure side, thereby accelerating OTM. In vitro, Yoda1 promoted the expression of RANKL/OPG in force-treated hPDLCs and osteoclastic differentiation of RAW264.7 cells mediated by force-treated hPDLCs. Furthermore, while our findings suggest that Yoda1 may serve as a potential therapeutic agent to accelerate OTM, caution must be exercised when considering clinical translation. The long-term safety profile, optimal dosing regimens, and potential off-target effects of Yoda1 remain largely unknown. Given that Piezo1 is expressed in various tissues, systemic activation could pose risks such as vascular, renal, or skeletal side effects [51]. Notably, in the Force + Yoda1 group, we observed a tendency toward increased root resorption compared with the Force + DMSO group. This observation aligns with recent studies suggesting that excessive activation of Piezo1 may enhance osteoclastic activity and contribute to root resorption during orthodontic tooth movement [52]. Therefore, further investigations are warranted to evaluate the dose-dependent effects of Piezo1 activation and to develop targeted strategies that enhance alveolar bone remodeling while minimizing undesirable outcomes such as root resorption. Future studies should therefore include comprehensive evaluations of Yoda1’s pharmacokinetics, toxicity, and tissue specificity. Additionally, it is important to recognize that biological differences between rats and humans, such as variations in bone remodeling dynamics and metabolic rates, may influence treatment outcomes [53]. Subsequent preclinical studies in larger animal models and eventual clinical trials will be necessary to validate the safety and efficacy of Piezo1-targeted therapies in orthodontic applications. The ERK1/2 signaling pathway plays an important role in bone remodeling during OTM, particularly in processes like osteoclast differentiation and the secretion of inflammatory factors [11, 54, 55]. In a variety of cell types, the intracellular influx of calcium is implicated in modulating ERK1/2 phosphorylation, subsequently affecting cellular functions [11, 56, 57]. Our study supports this by showing that ERK1/2 phosphorylation in PDLCs relies, at least in part, on Piezo1-mediated calcium influx. This finding is consistent with Jin et al.’s work, which demonstrated that mechanical force induces upregulation of TRPV4 and ERK1/2 phosphorylation in rat PDLSCs [11]. It has been broadly demonstrated that the phosphorylation of ERK is a crucial signal influencing the expression of RANKL in PDLCs under mechanical stress [7, 11, 15]. Moreover, the inhibition of ERK signaling by U0126, as shown in previous studies, also underscores the essential role of ERK1/2 in the mechanical stress response and OTM [58]. Nevertheless, further pharmacological validation will be necessary to firmly establish the causal relationship between Piezo1-mediated calcium influx and ERK1/2 activation. In particular, future studies using calcium chelators such as BAPTA-AM may help to directly confirm this mechanistic link. In addition to ERK1/2, other Piezo1-associated pathways such as YAP/TAZ and NF-κB may also play important roles in osteoclastogenesis under mechanical force and warrant further investigation. Despite these insights, there are also some constraints in the present study. Although we confirmed the role of PIEZO1 at the cellular level using siRNA-mediated knockdown, in the in vivo experiments, we relied on pharmacological inhibition with GsMTx4. As GsMTx4 is not exclusively selective for PIEZO1 and may inhibit other mechanosensitive ion channels [59], potential off-target effects could not be completely excluded. In the future, it will be necessary to establish genetically modified mice with a conditional knockout of Piezo1 in mesenchymal cells to explore the role of Piezo1 in the process of OTM. While the in vitro mechanical loading method employed in this study proved effective and widely applicable, it still cannot fully replicate in vivo loading conditions. Therefore, further investigation is warranted to explore more optimal in vitro loading methods in the future. In addition, while we used hPDLCs at passages 3–6 in accordance with established protocols in the field [7], we acknowledge that prolonged passaging may influence cellular phenotypes. Although we did not observe significant differences in PIEZO1 expression or mechanosensitivity within this range, future studies could further explore passage-dependent variations in mechanotransduction to enhance the understanding of PDLC biology. Conclusion In conclusion, our study demonstrates that compressive force activates Piezo1 in PDLCs, leading to an influx of calcium ions that subsequently triggers osteoclast differentiation and orthodontic bone remodeling through the ERK1/2 signaling pathway. Furthermore, we identified Yoda1 as a potential therapeutic agent capable of accelerating OTM by enhancing Piezo1 activation and calcium influx. These findings not only elucidate the mechanistic role of Piezo1 and calcium signaling in response to orthodontic force application but also suggest new avenues for improving orthodontic treatments. Supplementary Information Supplementary Material 1. Supplementary Material 2. Acknowledgements This study was financially supported by grants from the Beijing Natural Science Foundation (No.7232219). The graphical abstract of this study was drawn by Figdraw. Abbreviations 4',6-Diamidino-2-phenylindole Extracellular signal-regulated kinases 1/2 Hematoxylin and eosin Micro-computed tomography Osteoprotegerin Orthodontic tooth movement Periodontal ligament cells Periodontal ligament fibroblasts Quantitative real-time polymerase chain reaction The receptor activator of NF-kB ligand Tartrate-resistant acid phosphatase Authors’ contributions JH. J: Project administration, Funding acquisition, Supervision, Resources, Conceptualization, Validation, Writing-review and editing. CY. L: Supervision, Resources, Conceptualization, Validation, Writing-review and editing. F. Z: Methodology, Data curation, Writing-original draft. T. W & FF. W: Form analysis, Writing-review and editing. XY. C, HY. T, & P. C: Investigation, Writing-review and editing. All authors read and approved the final manuscript. Funding Beijing Natural Science Foundation (No.7232219). Data availability The datasets generated and analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate All research protocols were approved by the Ethics Committee of Peking University School of Stomatology, Beijing, China (PKUSSIRB-202385020). We obtained informed consent from all donors and their legal guardians prior to collecting samples. All animal experiments conducted in this study followed standard procedures and adhered to ethical principles for animal welfare. The animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Peking University (LA2022288). All methods are reported in accordance with ARRIVE guidelines for the reporting of animal experiments [60]. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Fu Zheng, Tong Wu and Feifei Wang contributed equally to this work and share first authorship. Contributor Information Cuiying Li, Email: kqlicuiying@bjmu.edu.cn. Jiuhui Jiang, Email: kqjiangjiuhui@bjmu.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1. Supplementary Material 2. Data Availability Statement The datasets generated and analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.